Interferon-alpha 2a up-regulated thymidine phosphorylase and enhanced antitumor effect of capecitabine on hepatocellular carcinoma in nude mice.
作者： Yong-Sheng Xiao , Zhao-You Tang , Jia Fan , Jian Zhou , Zhi-Quan Wu
DOI: 10.1007/S00432-004-0565-8
关键词:
摘要: Purpose To investigate the antitumor effect of interferon-alpha 2a (IFN-α2a) combined with capecitabine on hepatocellular carcinoma (HCC) in nude mice relation to thymidine phosphorylase (TP) expression.
springer.com
sci-hub.se 参考文章(23)
Hideo Ishitsuka, Capecitabine: preclinical pharmacology studies. Investigational New Drugs. ,vol. 18, pp. 343- 354 ,(2000) , 10.1023/A:1006497231579
Emily Wan, Edward L. Schwartz, Nicole Baptiste, Fu Shen Wang, Regulation of Expression of Thymidine Phosphorylase/Platelet-derived Endothelial Cell Growth Factor in Human Colon Carcinoma Cells Cancer Research. ,vol. 58, pp. 1551- 1557 ,(1998)
Miguel A. Villalona-Calero, Geoffrey R. Weiss, Howard A. Burris, Maura Kraynak, Gladys Rodrigues, Ronald L. Drengler, S. Gail Eckhardt, Bruno Reigner, Judy Moczygemba, Hans Ulrich Burger, Tom Griffin, Daniel D. Von Hoff, Eric K. Rowinsky, Phase I and Pharmacokinetic Study of the Oral Fluoropyrimidine Capecitabine in Combination With Paclitaxel in Patients With Advanced Solid Malignancies Journal of Clinical Oncology. ,vol. 17, pp. 1915- 1925 ,(1999) , 10.1200/JCO.1999.17.6.1915
Joanne L. Blum, Stephen E. Jones, Aman U. Buzdar, Patricia Mucci LoRusso, Irene Kuter, Charles Vogel, Bruno Osterwalder, Hans-Ulrich Burger, Cheryl Stoner Brown, Tom Griffin, Multicenter Phase II Study of Capecitabine in Paclitaxel-Refractory Metastatic Breast Cancer Journal of Clinical Oncology. ,vol. 17, pp. 485- 493 ,(1999) , 10.1200/JCO.1999.17.2.485
Jian Zhou, Zhao-You Tang, Jia Fan, Zhi-Quan Wu, Xiao-Ming Li, Yin-Kun Liu, Fei Liu, Hui-Chuan Sun, Sheng-Long Ye, Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus. Journal of Cancer Research and Clinical Oncology. ,vol. 126, pp. 57- 61 ,(2000) , 10.1007/S004320050009
Kunio Okuda, , Primary liver cancers in Japan Cancer. ,vol. 45, pp. 2663- 2669 ,(1980) , 10.1002/1097-0142(19800515)45:10<2663::AID-CNCR2820451030>3.0.CO;2-G
Fuyuki Ishikawa, Kohei Miyazono, Ulf Hellman, Hannes Drexler, Christer Wernstedt, Koichi Hagiwara, Kensuke Usuki, Fumimaro Takaku, Werner Risau, Carl-Henrik Heldin, Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature. ,vol. 338, pp. 557- 562 ,(1989) , 10.1038/338557A0
Fan X. Sun, Zhao Y. Tang, Kang D. Liu, Sheng L. Ye, Qiong Xue, Dong M. Gao, Zeng C. Ma, Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues International Journal of Cancer. ,vol. 66, pp. 239- 243 ,(1996) , 10.1002/(SICI)1097-0215(19960410)66:2<239::AID-IJC17>3.0.CO;2-7
D. Maxwell Parkin, Freddie Bray, Jacques Ferlay, Paola Pisani, Estimating the world cancer burden: Globocan 2000 International Journal of Cancer. ,vol. 94, pp. 153- 156 ,(2001) , 10.1002/IJC.1440
Tohru Ishikawa, Masahiro Utoh, Noriaki Sawada, Miwa Nishida, Yu Fukase, Fumiko Sekiguchi, Hideo Ishitsuka, Tumor Selective Delivery of 5-Fluorouracil by Capecitabine, a New Oral Fluoropyrimidine Carbamate, in Human Cancer Xenografts Biochemical Pharmacology. ,vol. 55, pp. 1091- 1097 ,(1998) , 10.1016/S0006-2952(97)00682-5